A detailed history of Wetzel Investment Advisors, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Wetzel Investment Advisors, Inc. holds 9,556 shares of LLY stock, worth $7.6 Million. This represents 4.37% of its overall portfolio holdings.

Number of Shares
9,556
Previous 9,451 1.11%
Holding current value
$7.6 Million
Previous $8.56 Million 1.05%
% of portfolio
4.37%
Previous 4.92%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$772.14 - $960.02 $81,074 - $100,802
105 Added 1.11%
9,556 $8.47 Million
Q2 2024

Aug 07, 2024

BUY
$724.87 - $909.04 $63,788 - $79,995
88 Added 0.94%
9,451 $8.56 Million
Q1 2024

Apr 23, 2024

SELL
$592.2 - $792.28 $132,060 - $176,678
-223 Reduced 2.33%
9,363 $7.28 Million
Q4 2023

Jan 31, 2024

BUY
$525.19 - $619.13 $5.03 Million - $5.93 Million
9,586 New
9,586 $5.59 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Wetzel Investment Advisors, Inc. Portfolio

Follow Wetzel Investment Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wetzel Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Wetzel Investment Advisors, Inc. with notifications on news.